Matches in Wikidata for { <http://www.wikidata.org/entity/Q66407765> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q66407765 description "assaig clínic" @default.
- Q66407765 description "clinical trial" @default.
- Q66407765 description "clinical trial" @default.
- Q66407765 description "clinical trial" @default.
- Q66407765 description "clinical trial" @default.
- Q66407765 description "ensaio clínico" @default.
- Q66407765 description "ensayo clínico" @default.
- Q66407765 description "ensayu clínicu" @default.
- Q66407765 description "essai clinique" @default.
- Q66407765 description "klinisch onderzoek" @default.
- Q66407765 description "клінічне випробування" @default.
- Q66407765 name "EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis" @default.
- Q66407765 name "EMBRACE-SC: Observational Study of Subcutaneous" @default.
- Q66407765 type Item @default.
- Q66407765 label "EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis" @default.
- Q66407765 label "EMBRACE-SC: Observational Study of Subcutaneous" @default.
- Q66407765 prefLabel "EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis" @default.
- Q66407765 prefLabel "EMBRACE-SC: Observational Study of Subcutaneous" @default.
- Q66407765 P1050 Q66407765-D65BE5FB-D7F5-47C0-90B2-566E16901C1E @default.
- Q66407765 P1132 Q66407765-F9ACA07F-652E-4B35-B0EE-29F079B58CAD @default.
- Q66407765 P1476 Q66407765-00857F54-EAE7-4880-91F5-42BAD170A3BA @default.
- Q66407765 P17 Q66407765-1D391C21-8E03-41F1-B45F-9B914CFE49DD @default.
- Q66407765 P2899 Q66407765-C498C172-0542-407B-86C7-864E2CD6DAA5 @default.
- Q66407765 P3098 Q66407765-7B383CA4-A675-4DC4-AB9E-CBCE1E94FBEE @default.
- Q66407765 P31 Q66407765-3E854CDC-9B5D-49AA-B837-F6C431D138BA @default.
- Q66407765 P580 Q66407765-F954EE76-DB25-41C4-A58C-9AEB97B4F2C5 @default.
- Q66407765 P582 Q66407765-7C9CF943-0C34-4A5D-A3BE-27319DE397F7 @default.
- Q66407765 P8363 Q66407765-23D12863-C6C7-4EFA-BDAC-E69B75FD916D @default.
- Q66407765 P859 Q66407765-558B0AC3-E047-484D-A5FC-7F9979702F2E @default.
- Q66407765 P1050 Q170990 @default.
- Q66407765 P1132 "+200" @default.
- Q66407765 P1476 "Multicenter, Post-Marketing, Non-Interventional, Observational Study to Evaluate Persistence to Tocilizumab SC as Monotherapy or in Combination With cDMARD Treatment in RA Patients in Greece: the EMBRACE-SC Study." @default.
- Q66407765 P17 Q41 @default.
- Q66407765 P2899 "+18" @default.
- Q66407765 P3098 "NCT02648035" @default.
- Q66407765 P31 Q30612 @default.
- Q66407765 P580 "2016-09-22T00:00:00Z" @default.
- Q66407765 P582 "2018-12-20T00:00:00Z" @default.
- Q66407765 P8363 Q818574 @default.
- Q66407765 P859 Q212646 @default.